HCC tumors with active TGF-β signatures display abundant expression of oncogenes (e.g., KRAS, MDM2, MTOR, IGF2, and VEGFA), strengthening the model that a functional link exists between tumor promoting TGF-β and oncogenic circuits [164]. This evidence concerns the gene VEGFA and neoplasm.